Evaluating a new way to open clogged arteries
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
Cardiology
22 hours ago |
4.7 / 5 (6) |
0
|
Two new papers on dabigatran etexilate (Pradaxa) and intracranial hemorrhage
The Journal of Neurosurgery Publishing Group is pleased to announce publication of two new studies on dabigatran etexilate (Pradaxa®) and intracranial hemorrhage: one in the Journal of Neurosurgery and the other in Neur ...
Surgery
May 01, 2013 |
not rated yet |
0
Tart cherries linked to reduced risk of stroke
(Medical Xpress)—For the millions of Americans at risk for heart disease or diabetes, a diet that includes tart cherries might actually be better than what the doctor ordered, according to new animal research ...
Health
Apr 24, 2013 |
3.8 / 5 (4) |
0
|
Study says more efforts needed to regulate dietary supplements
Dietary supplements accounted for more than half the Class 1 drugs recalled by the U.S. Food and Drug Administration from 2004-12, meaning they contained substances that could cause serious health problems or even death, ...
Health
Apr 18, 2013 |
not rated yet |
0
Despite superbug crisis, progress in antibiotic development 'alarmingly elusive'
Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society ...
Diseases, Conditions, Syndromes
Apr 18, 2013 |
not rated yet |
0
FDA approves Phase II of stem cell trial for ALS
For nearly two years, University of Michigan neurologist Eva Feldman, M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral ...
Medical research
Apr 17, 2013 |
not rated yet |
0
Fecal microbial transplantation found to be possible treatment
A Spectrum Health clinical trial has found that fecal microbial transplantation (FMT) has resulted in the improvement or absence of symptoms in most pediatric patients with active ulcerative colitis.
Diseases, Conditions, Syndromes
Apr 05, 2013 |
not rated yet |
0
CWRU spinoff ConservoCare gets licensing options to develop medical device for bladder control
ConservoCare, LLC, a spinoff of research at Case Western Reserve University, has obtained license options through the university's Technology Transfer Office to develop a medical device for bladder control.
Other
Mar 15, 2013 |
not rated yet |
0
Pharmaceutical advertising down but not out, study says
The pharmaceutical industry has pulled back on marketing to physicians and consumers, yet some enduring patterns persist. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, ...
Medications
Mar 04, 2013 |
not rated yet |
0
|
Before deciding on breast implants, consider FDA precautions
(HealthDay)—If you're thinking about getting breast implants, there are some things you need to know before you make your decision, according to the U.S. Food and Drug Administration.
Other
Feb 27, 2013 |
2.5 / 5 (2) |
1
FDA approves new silicone gel-filled breast implant
(HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years ...
Other
Feb 21, 2013 |
not rated yet |
0
Long-term side-effects of targeted therapies in pediatric cancer patients
A University of Colorado Cancer Center review published this week in the journal Lancet Oncology describes possible long-term side-effects of new, targeted therapies in pediatric cancer patients: what we don't know may hu ...
Cancer
Feb 07, 2013 |
not rated yet |
0
Researchers confirm value of flow-diverting device for most challenging aneurysms
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that ...
Neuroscience
Jan 30, 2013 |
not rated yet |
0
FDA panel recommends against 1st drug for chronic fatigue syndrome
(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.
Medications
Dec 21, 2012 |
1 / 5 (1) |
1
|
Innovative, off-road wheelchairs hit the US market
The rugged, low-cost wheelchairs designed by SF State's Whirlwind Wheelchair program have helped thousands of people in developing countries. Now they're available in the U.S., where they are opening up new ...
Health
Dec 14, 2012 |
4.8 / 5 (4) |
0
